IMCAS Academy

Inscribirse

Conectarse

Presentación
Programa
Oradores
Listado de sponsors
Acreditación

VOLVER

IMCAS World Congress 2024
Programa

Adapte el horario de la clase / congreso transmitido en vivo a su zona horaria

Referencia de zona horaria: (UTC+02:00) Europe, Paris

Zona horaria

Zona horaria:Cambiar zona horaria

If you are logged in, change your default time zone in your account

FOCO EN 219

CHAMEDITECH Symposium - How to make the skin glow with soft injection

Descubra los últimos videos y noticias de CHAMEDITECH's

Sala: Room 252 - Level 2
Fecha: sábado 3 febrero 2024 de 14:00 a 15:30
Formato: SIMPOSIA DE LA INDUSTRIA > Sesión promocional y educativa por parte de la empresa organizadora que presenta sus productos y servicios directamente a los asistentes.

Las presentaciones

Horas	Oradores	Título de la presentación	Resumen	Número
14:00	Dr Huray HUGUL	New era illumination and antiaging protocol	Ver	135139
14:45	Dr Jose Ramon VAZQUEZ CASAS	IFRHA® Methodology (Isovolumetric facial replacement of Hyaluronic Acid)	Ver	135140

Ver sesiones anteriores

Ver la siguiente sesión

Sesiones recomendadas

Rellenos: HA

Dr Huray HUGUL

Dermatólogo

Turquía

Otro(s) autor(es) :

New era illumination and antiaging protocol

Objectives: Our aim is evaluating weakly cross linked hyaluronic acid transparent gel-type product ''Dorothy'' in our patients facial and neck skin areas rejuvenation. This product is a colourless transparent gel-type product with viscoelasticity composed of a stabilized non-animal hyaluronic acid.

Introduction: We have evaluated 1 male and 8 female totally 9 patients with Dorothy. We have measured their skin quality; thickness, pores, sebum distrubition, UV damage, UV pigmentation, telangiectasias, wrinkle distribution, moisture ratio, sensitive areas and the age of skin with a dermatological skin quality measuring equipment ''pHFormula Machine'' before the treatment and after the treatment.

Materials / method: We have contributed 9 patients to this study. 1 male and 8 female. (The M/F ratio is 1/8). We have applied 6 patients whole the 9 ml hyaluronic acid enjections at one session. 9 ML PROCEDURE (at one session) We have applied 3 patients; hyaluronic acid enjection at two to three sessions. POLYSHOT PROCEDURE (more than 1 session). The ratio of 9 ML PROCEDURE/POLYSHOT PROCEDURE is %66,6.

Results: Hyaluronic acid is used for facial tissue augmentation into areas in which restoration is required also helps to improve the skin quality. 9 ML PROCEDURE was significantly more effective than POLYSHOT PROCEDURE in skin improvement, wrinkle reduction, decreasing UV damage and UV hyperpigmentation.

Conclusion: We know that hyaluronic acid is used for facial tissue augmentation into areas in which restoration is required also helps to improve the skin quality. Our study has shown that 9 ML PROCEDURE was significantly more effective than POLYSHOT PROCEDURE in skin improvement, wrinkle reduction, decreasing UV damage and UV hyperpigmentation.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: CHAMEDITECH

Dr Jose Ramon VAZQUEZ CASAS

Médico Internista

España

Otro(s) autor(es) :

IFRHA® Methodology (Isovolumetric facial replacement of Hyaluronic Acid)

Objectives: The objective of the implementation of the IFRHA® methodology is to replace this synthesis deficit locally with very high doses of HA, with a hydrobooster that does not generate volume or changes in facial structure.

Introduction: The synthesis capacity of hyaluronic acid (HA) decreases throughout the life of a human being, which leads to morphological and functional changes in our skin. This decrease in its synthesis is much more evident in specific periods of life. One of these periods where this process is accelerated is the peri- and postmenopausal period of women, where the decrease in estrogen receptors and levels (much more evident in facial skin), causes very rapid changes in the quality of the skin: decreased skin thickness, atrophy, loss of elasticity, dehydration and increased the wrinkles.

Materials / method: A descriptive observational cohort study was carried out on 15 female patients over 50 years of age, where the safety and efficacy of intradermal injection with high dose at the facial level of a hydrobooster with minimally cross-linked HA (Dorothy®) has been evaluated. Using a fan and linear threading technique, 2 sessions were carried out separated by 1 month and the results were assessed 3 months after the first session. A photographic study was carried out, a sample of the basic skin parameters was taken with a probe and the pain scale and the degree of patient satisfaction were recorded.

Results: The results obtained with intradermotherapy with high doses of a hydrobooster such as Dorothy®, have been able to demonstrate the high effectiveness of this procedure, with significant improvement in all the basic parameters of the skin, being a safe procedure, very minimally invasive and with minimal side effects. All patients reported a high degree of satisfaction.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

¿Tiene una pregunta?

Encuentre las respuestas rápidamente en nuestra sección de FAQ.

Congresos

IMCAS Americas
IMCAS Asia
IMCAS World Congress

Acerca de

Empresa
Política de Confidencialidad
Mención legal

Academy

Inicio
Cursos
Webinars
Explorar
Blog

Subvenciones

Subvención educativa

Ponerse en contacto

Contáctenos

Nombre de usuario/Email

Contraseña

Mantenerme conectado

Iniciar sesión

Olvidé mi contraseña ? Todavía no tiene una cuenta? Inscríbase ahora